{{Rsnum
|rsid=2251301
|Chromosome=8
|position=11261528
|Orientation=plus
|GMAF=0.08953
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 68.1 | 30.1 | 1.8
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 95.9 | 4.1 | 0.0
| ASW | 91.2 | 8.8 | 0.0
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 63.4 | 33.7 | 3.0
| LWK | 89.1 | 10.0 | 0.9
| MEX | 84.5 | 15.5 | 0.0
| MKK | 93.6 | 6.4 | 0.0
| TSI | 76.5 | 22.5 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19875103
|Trait=Response to antipsychotic therapy (extrapyramidal side effects)
|Title=Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects
|RiskAllele=
|Pval=0.000001
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2251301
|overall_frequency_n=14
|overall_frequency_d=128
|overall_frequency=0.109375
|n_genomes=10
|n_genomes_annotated=0
|n_haplomes=11
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}